A Phase II Study of Triple-negative Breast Cancer Brain Metastases.
A Prospective, Single-arm, Single-center, Phase II Clinical Study of Triple-negative Breast Cancer Brain Metastases
Sponsor: Fudan University
Listed as NCT04303988, this PHASE2 trial focuses on Breast Cancer and remains actively recruiting participants. Sponsored by Fudan University, it has been updated 6 times since 2020, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE2
Status: Unknown → Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Apr 2022 — Jul 2024 [monthly]
Unknown Status PHASE2
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Not Yet Recruiting PHASE2
▶ Show 1 earlier version
-
Apr 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fudan University
For direct contact, visit the study record on ClinicalTrials.gov .